371 related articles for article (PubMed ID: 28653397)
41. Expression of CD4 is correlated with an unfavorable prognosis in wild-type NPM1, FLT3-ITD-negative cytogenetically normal adult acute myeloid leukemia.
Guo RJ; Atenafu EG; Schimmer AD; Minden MD; Chang H
Int J Lab Hematol; 2017 Aug; 39(4):429-437. PubMed ID: 28318150
[TBL] [Abstract][Full Text] [Related]
42. Fms like tyrosine kinase (FLT3) and nucleophosmin 1 (NPM1) mutations in de novo normal karyotype acute myeloid leukemia (AML).
Dunna NR; Rajappa S; Digumarti R; Vure S; Kagita S; Damineni S; Rao VR; Yadav SK; Ravuri RR; Satti V
Asian Pac J Cancer Prev; 2010; 11(6):1811-6. PubMed ID: 21338238
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.
Renneville A; Boissel N; Nibourel O; Berthon C; Helevaut N; Gardin C; Cayuela JM; Hayette S; Reman O; Contentin N; Bordessoule D; Pautas C; Botton Sd; Revel Td; Terre C; Fenaux P; Thomas X; Castaigne S; Dombret H; Preudhomme C
Leukemia; 2012 Jun; 26(6):1247-54. PubMed ID: 22289988
[TBL] [Abstract][Full Text] [Related]
44. Reversal of FLT3 mutational status and sustained expression of NPM1 mutation in paired presentation, and relapse samples in a patient with acute myeloid leukemia.
Radojkovic M; Tosic N; Colovic N; Ristic S; Pavlovic S; Colovic M
Ann Clin Lab Sci; 2012; 42(2):186-90. PubMed ID: 22585616
[TBL] [Abstract][Full Text] [Related]
45. Prevalence and prognostic significance of FLT3 gene mutations in patients with acute leukaemia: analysis of patients from the Shanghai Leukaemia Co-operative Group.
Wang W; Wang XQ; Xu XP; Lin GW
J Int Med Res; 2010; 38(2):432-42. PubMed ID: 20515557
[TBL] [Abstract][Full Text] [Related]
46. Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD.
Ho AD; Schetelig J; Bochtler T; Schaich M; Schäfer-Eckart K; Hänel M; Rösler W; Einsele H; Kaufmann M; Serve H; Berdel WE; Stelljes M; Mayer J; Reichle A; Baldus CD; Schmitz N; Kramer M; Röllig C; Bornhäuser M; Thiede C; Ehninger G;
Biol Blood Marrow Transplant; 2016 Mar; 22(3):462-9. PubMed ID: 26551637
[TBL] [Abstract][Full Text] [Related]
47. [Research Advance of Gene Mutation and Targeted Drug Therapy in Childhood Acute Myeloid Leukemia --Review].
DU CK; Lu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):631-635. PubMed ID: 35396009
[TBL] [Abstract][Full Text] [Related]
48. Gene expression profiling in acute myeloid leukaemia (AML).
Bacher U; Kohlmann A; Haferlach C; Haferlach T
Best Pract Res Clin Haematol; 2009 Jun; 22(2):169-80. PubMed ID: 19698926
[TBL] [Abstract][Full Text] [Related]
49. Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by flow cytometry is associated with NPM1 and FLT3 mutation status in cytogenetically normal acute myeloid leukemia.
Dalal BI; Mansoor S; Manna M; Pi S; Sauro GD; Hogge DE
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):274-9. PubMed ID: 22481022
[TBL] [Abstract][Full Text] [Related]
50. Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia.
How J; Sykes J; Gupta V; Yee KW; Schimmer AD; Schuh AC; Minden MD; Kamel-Reid S; Brandwein JM
Cancer; 2012 Dec; 118(24):6110-7. PubMed ID: 22736495
[TBL] [Abstract][Full Text] [Related]
51. Gene expression profiling for the diagnosis and prognosis of acute myeloid leukaemia.
Mills K
Front Biosci; 2008 May; 13():4605-16. PubMed ID: 18508532
[TBL] [Abstract][Full Text] [Related]
52. The complexity of interpreting genomic data in patients with acute myeloid leukemia.
Nazha A; Zarzour A; Al-Issa K; Radivoyevitch T; Carraway HE; Hirsch CM; Przychodzen B; Patel BJ; Clemente M; Sanikommu SR; Kalaycio M; Maciejewski JP; Sekeres MA
Blood Cancer J; 2016 Dec; 6(12):e510. PubMed ID: 27983727
[TBL] [Abstract][Full Text] [Related]
53. New insights in AML biology from genomic analysis.
Perry AM; Attar EC
Semin Hematol; 2014 Oct; 51(4):282-97. PubMed ID: 25311741
[TBL] [Abstract][Full Text] [Related]
54. [Diagnosis and Therapy of Acute Myeloid Leukemia].
Medinger M; Heim D; Halter JP; Lengerke C; Passweg JR
Ther Umsch; 2019; 76(9):481-486. PubMed ID: 32157963
[TBL] [Abstract][Full Text] [Related]
55. Advances in Acute Myeloid Leukemia Genomics, Where Do We Stand in 2018?
Madanat YF; Kalaycio ME; Nazha A
Acta Med Acad; 2019 Apr; 48(1):35-44. PubMed ID: 31264431
[TBL] [Abstract][Full Text] [Related]
56. [Importance of gene mutation analysis as prognostic factor of acute myeloid leukemia].
Yamaguchi H
Rinsho Ketsueki; 2020; 61(9):1160-1165. PubMed ID: 33162511
[TBL] [Abstract][Full Text] [Related]
57. Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication.
Jahn N; Terzer T; Sträng E; Dolnik A; Cocciardi S; Panina E; Corbacioglu A; Herzig J; Weber D; Schrade A; Götze K; Schröder T; Lübbert M; Wellnitz D; Koller E; Schlenk RF; Gaidzik VI; Paschka P; Rücker FG; Heuser M; Thol F; Ganser A; Benner A; Döhner H; Bullinger L; Döhner K
Blood Adv; 2020 Dec; 4(24):6342-6352. PubMed ID: 33351131
[TBL] [Abstract][Full Text] [Related]
58. Clonal hierarchy of main molecular lesions in acute myeloid leukaemia.
Herudkova Z; Culen M; Folta A; Jeziskova I; Cerna J; Loja T; Tom N; Smejkal J; Semerad L; Dvorakova D; Mayer J; Racil Z
Br J Haematol; 2020 Aug; 190(4):562-572. PubMed ID: 31822038
[TBL] [Abstract][Full Text] [Related]
59. Precision therapy for acute myeloid leukemia.
Yang X; Wang J
J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553
[TBL] [Abstract][Full Text] [Related]
60. Recent advances in the understanding and treatment of acute myeloid leukemia.
Watts J; Nimer S
F1000Res; 2018; 7():. PubMed ID: 30135719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
